IBDEI1JM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24666,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,24666,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,24667,0)
 ;;=N18.2^^107^1208^16
 ;;^UTILITY(U,$J,358.3,24667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24667,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,24667,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,24667,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,24668,0)
 ;;=N18.3^^107^1208^17
 ;;^UTILITY(U,$J,358.3,24668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24668,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,24668,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,24668,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,24669,0)
 ;;=N18.4^^107^1208^18
 ;;^UTILITY(U,$J,358.3,24669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24669,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,24669,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,24669,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,24670,0)
 ;;=N18.5^^107^1208^19
 ;;^UTILITY(U,$J,358.3,24670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24670,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,24670,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,24670,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,24671,0)
 ;;=Q61.3^^107^1208^87
 ;;^UTILITY(U,$J,358.3,24671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24671,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,24671,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,24671,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,24672,0)
 ;;=N20.1^^107^1208^11
 ;;^UTILITY(U,$J,358.3,24672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24672,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,24672,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,24672,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,24673,0)
 ;;=N18.9^^107^1208^20
 ;;^UTILITY(U,$J,358.3,24673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24673,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,24673,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,24673,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,24674,0)
 ;;=N18.6^^107^1208^30
 ;;^UTILITY(U,$J,358.3,24674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24674,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,24674,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,24674,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,24675,0)
 ;;=N52.9^^107^1208^47
 ;;^UTILITY(U,$J,358.3,24675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24675,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,24675,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,24675,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,24676,0)
 ;;=N32.81^^107^1208^82
 ;;^UTILITY(U,$J,358.3,24676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24676,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,24676,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,24676,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,24677,0)
 ;;=Q61.2^^107^1208^86
 ;;^UTILITY(U,$J,358.3,24677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24677,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,24677,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,24677,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,24678,0)
 ;;=N41.1^^107^1208^90
 ;;^UTILITY(U,$J,358.3,24678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24678,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,24678,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,24678,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,24679,0)
 ;;=N11.9^^107^1208^98
